S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Spotlight InnovationPropanc BiopharmaSkinvisibleOrexigen TherapeuticsInspyr Therapeutics
SymbolOTCMKTS:STLTOTCMKTS:PPCBOTCMKTS:SKVIOTCMKTS:OREXQOTCMKTS:NSPX
Price Information
Current Price$0.01$0.03$0.09$0.01$0.02
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$286,000.00$130,000.00$264,000.00$100,000.00$193,000.00
Beta-2.414.23-1.034.98-17.23
Average Volume1,1881,381,9302,76129,68835,345,208
Sales & Book Value
Annual RevenueN/AN/A$70,000.00$33.71 millionN/A
Price / SalesN/AN/A3.770.00N/A
CashflowN/AN/A$0.23 per shareN/A$1.70 per share
Price / CashN/AN/A0.39N/A0.01
Book ValueN/A($4.61) per share($1.63) per shareN/A($21.58) per share
Price / BookN/AN/A-0.06N/A
Profitability
Net Income$-6,160,000.00$-5,760,000.00$160,000.00$-24,520,000.00$-10,000.00
EPSN/AN/AN/AN/AN/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-3,243.81%N/AN/A
Return on Equity (ROE)N/AN/AN/AN/A-20.31%
Return on Assets (ROA)N/A-3,549.64%-689.06%N/A683.37%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/AN/A0.01%N/A0.01%
Quick RatioN/AN/A0.01%N/A0.01%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/A0.02%53.00%13.30%0.02%
Miscellaneous
Employees413N/A7
Shares Outstanding35.76 million5.19 million2.90 million18.89 million11.38 million
Next Earnings DateN/A5/20/2020 (Estimated)5/22/2020 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel